XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E903. A total of 3 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273 | -28.2% | 146,800 | +1.0% | 0.00% | – |
| Q2 2023 | $380 | +155.0% | 145,300 | +57.9% | 0.00% | – |
| Q1 2023 | $149 | -42.7% | 92,000 | -52.9% | 0.00% | – |
| Q4 2022 | $260 | -99.9% | 195,500 | +14.5% | 0.00% | – |
| Q3 2022 | $266,000 | -14.2% | 170,700 | -15.2% | 0.00% | – |
| Q2 2022 | $310,000 | -1.3% | 201,400 | +64.0% | 0.00% | – |
| Q1 2022 | $314,000 | +10.2% | 122,800 | +25.9% | 0.00% | – |
| Q4 2021 | $285,000 | – | 97,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 126,600 | $206,358 | 0.00% |
| SIMPLEX TRADING, LLC | 92,000 | $149 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |